Ropes & Gray Represents TPG Capital LP-backed Par Pharmaceutical Companies Inc. in its $490M acquisition of JHP Group Holdings LLC.

In The News
January 24, 2014

A team of Ropes & Gray attorneys advised Par Pharmaceutical Companies Inc., a pharmaceutical company engaged in developing, licensing, manufacturing, marketing, and distributing generic and branded products, in its acquisition of JHP Group Holdings, a pharmaceutical company that acquires, develops, manufactures and sells sterile injectable drugs, from Warburg Pincus for approximately $490 million.

The deal was publicly announced on January 21, 2014.

The Ropes & Gray team was led by private equity partner William Shields and included finance partner Alexander Zeltser.